[Strategies for pharmaceutical research and development. II. Generic drugs].
When the patent protection is terminated, the original registered-mark preparation becomes a generic drug, which results in a decrease in its price as compared with the original pharmaceutical. The effects of changes in price relation are discussed from the viewpoint of the generic firms and the manufacturers of original preparations. The differences in the insurance system and legislative regulations of the registration of generic preparations can markedly the size influence of the share of generic drugs in the total consumption of drugs. The future development of generic drugs from a general viewpoint is discussed in relation to the contemporary extensive expiration of patent protection of drugs. The hitherto results are summed up and the topics for the present strategy of the development of generic drugs in the Research Institute for Pharmacy and Biochemistry, or in the Czech Republic, respectively are discussed.
Kuchar
M
M
Výzkumný ústav pro farmacii a biochemii, Praha.
D018153:Czech Republic; D004345:Drug Industry; D016568:Drugs, Generic / Q000191:economics; D013678:Technology, Pharmaceutical
D016568:Drugs, Generic